Stephen Barker
Stock Analyst at Jefferies
(3.72)
# 2,074
Out of 5,000 analysts
119
Total ratings
45.2%
Success rate
10%
Average return
Main Sectors:
Stocks Rated by Stephen Barker
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| TYO: 4506 Sumitomo Pharma Co., Ltd. | Reiterated: Buy | ¥2,400 → ¥2,700 | ¥1,590 | +69.86% | 11 | Sep 14, 2026 | |
| TYO: 4151 Kyowa Kirin Co., Ltd. | Downgraded: Hold | ¥2,800 → ¥2,600 | ¥2,262 | +14.97% | 6 | Sep 8, 2026 | |
| TYO: 4578 Otsuka Holdings Co., Ltd. | Reiterated: Buy | ¥12,700 → ¥14,000 | ¥11,040 | +26.81% | 13 | Sep 7, 2026 | |
| TYO: 6869 Sysmex Corporation | Reiterated: Hold | ¥1,700 → ¥2,100 | ¥1,854 | +13.27% | 5 | Aug 27, 2026 | |
| TYO: 7733 Olympus Corporation | Reiterated: Buy | ¥2,300 → ¥3,300 | ¥1,995 | +65.41% | 5 | Aug 27, 2026 | |
| TYO: 4502 Takeda Pharmaceutical Company Limited | Reiterated: Buy | ¥6,800 → ¥7,100 | ¥5,885 | +20.65% | 6 | Aug 21, 2026 | |
| TYO: 4568 Daiichi Sankyo Company, Limited | Downgraded: Hold | ¥3,100 → ¥3,000 | ¥2,880 | +4.17% | 14 | Jul 30, 2026 | |
| TYO: 4519 Chugai Pharmaceutical Co., Ltd. | Reiterated: Hold | ¥8,500 → ¥8,000 | ¥6,650 | +20.30% | 8 | Jul 26, 2026 | |
| TYO: 2160 GNI Group Ltd. | Reiterated: Buy | ¥3,800 | ¥3,395 | +11.93% | 4 | Jul 13, 2026 | |
| TYO: 4528 Ono Pharmaceutical Co., Ltd. | Reiterated: Hold | ¥1,800 → ¥2,500 | ¥2,408 | +3.84% | 3 | May 29, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | ¥4,200 → ¥4,500 | ¥3,338 | +34.81% | 8 | May 29, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | ¥5,000 → ¥4,000 | ¥4,902 | -18.40% | 9 | May 28, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | ¥1,500 | ¥1,441 | +4.09% | 1 | Apr 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | ¥1,500 → ¥2,800 | ¥2,359 | +18.69% | 7 | Mar 24, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | ¥1,900 → ¥1,700 | ¥1,736 | n/a | 2 | Aug 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | ¥7,400 → ¥2,500 | ¥2,918 | n/a | 3 | Oct 25, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | ¥3,400 → ¥4,100 | ¥3,506 | n/a | 4 | Oct 21, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | ¥560 → ¥660 | ¥501 | n/a | 2 | Sep 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | ¥320 | ¥294 | n/a | 1 | Sep 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | ¥3,350 → ¥3,500 | ¥2,275 | n/a | 4 | Sep 2, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | ¥2,700 | ¥1,057 | n/a | 1 | Aug 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | ¥3,600 | ¥3,995 | n/a | 1 | Jul 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | n/a | $661.10 | n/a | 1 | Feb 1, 2019 |
Sumitomo Pharma Co., Ltd.
Sep 14, 2026
Reiterated: Buy
Price Target: ¥2,400 → ¥2,700
Current: ¥1,590
Upside: +69.86%
Kyowa Kirin Co., Ltd.
Sep 8, 2026
Downgraded: Hold
Price Target: ¥2,800 → ¥2,600
Current: ¥2,262
Upside: +14.97%
Otsuka Holdings Co., Ltd.
Sep 7, 2026
Reiterated: Buy
Price Target: ¥12,700 → ¥14,000
Current: ¥11,040
Upside: +26.81%
Sysmex Corporation
Aug 27, 2026
Reiterated: Hold
Price Target: ¥1,700 → ¥2,100
Current: ¥1,854
Upside: +13.27%
Olympus Corporation
Aug 27, 2026
Reiterated: Buy
Price Target: ¥2,300 → ¥3,300
Current: ¥1,995
Upside: +65.41%
Takeda Pharmaceutical Company Limited
Aug 21, 2026
Reiterated: Buy
Price Target: ¥6,800 → ¥7,100
Current: ¥5,885
Upside: +20.65%
Daiichi Sankyo Company, Limited
Jul 30, 2026
Downgraded: Hold
Price Target: ¥3,100 → ¥3,000
Current: ¥2,880
Upside: +4.17%
Chugai Pharmaceutical Co., Ltd.
Jul 26, 2026
Reiterated: Hold
Price Target: ¥8,500 → ¥8,000
Current: ¥6,650
Upside: +20.30%
GNI Group Ltd.
Jul 13, 2026
Reiterated: Buy
Price Target: ¥3,800
Current: ¥3,395
Upside: +11.93%
Ono Pharmaceutical Co., Ltd.
May 29, 2026
Reiterated: Hold
Price Target: ¥1,800 → ¥2,500
Current: ¥2,408
Upside: +3.84%
May 29, 2026
Reiterated: Buy
Price Target: ¥4,200 → ¥4,500
Current: ¥3,338
Upside: +34.81%
May 28, 2026
Reiterated: Hold
Price Target: ¥5,000 → ¥4,000
Current: ¥4,902
Upside: -18.40%
Apr 30, 2026
Reiterated: Hold
Price Target: ¥1,500
Current: ¥1,441
Upside: +4.09%
Mar 24, 2026
Reiterated: Buy
Price Target: ¥1,500 → ¥2,800
Current: ¥2,359
Upside: +18.69%
Aug 8, 2025
Downgraded: Hold
Price Target: ¥1,900 → ¥1,700
Current: ¥1,736
Upside: n/a
Oct 25, 2024
Reiterated: Hold
Price Target: ¥7,400 → ¥2,500
Current: ¥2,918
Upside: n/a
Oct 21, 2024
Reiterated: Hold
Price Target: ¥3,400 → ¥4,100
Current: ¥3,506
Upside: n/a
Sep 11, 2024
Reiterated: Hold
Price Target: ¥560 → ¥660
Current: ¥501
Upside: n/a
Sep 9, 2024
Upgraded: Buy
Price Target: ¥320
Current: ¥294
Upside: n/a
Sep 2, 2024
Reiterated: Buy
Price Target: ¥3,350 → ¥3,500
Current: ¥2,275
Upside: n/a
Aug 1, 2024
Reiterated: Hold
Price Target: ¥2,700
Current: ¥1,057
Upside: n/a
Jul 30, 2024
Reiterated: Hold
Price Target: ¥3,600
Current: ¥3,995
Upside: n/a
Feb 1, 2019
Upgraded: Buy
Price Target: n/a
Current: $661.10
Upside: n/a